A test designed to detect even the smallest trace of diseased cells found in the bone marrow of children with acute lymphoblastic leukemia can determine the risk of possible relapses ahead of time, according to a study in the journal Leukaemia. Australian researchers used the test in 1,000 pediatric ALL patients and found the method increased the survival rate to 75% and saved the lives of approximately 30 to 40 children.

Related Summaries